KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Inventory Average (2016 - 2026)

Edwards Lifesciences has reported Inventory Average over the past 16 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Inventory Average rose 3.48% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 3.48%, while the annual FY2025 figure was $1.1 billion, 11.19% up from the prior year.
  • Inventory Average for Q4 2025 was $1.1 billion at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $1.1 billion in Q3 2025 and troughed at $728.6 million in Q1 2022.
  • A 5-year average of $935.5 million and a median of $957.6 million in 2023 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: decreased 7.19% in 2022 and later soared 34.37% in 2023.
  • Year by year, Inventory Average stood at $732.2 million in 2021, then grew by 11.53% to $816.6 million in 2022, then increased by 18.53% to $968.0 million in 2023, then grew by 13.17% to $1.1 billion in 2024, then increased by 3.48% to $1.1 billion in 2025.
  • Business Quant data shows Inventory Average for EW at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.